Estimating the Adherence Rate of a Monthly Bubble Package Among Women Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Estimating the Adherence Rate of a Monthly Bubble Package Among Women Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors
This study uses Bubble packaging to provide a cost effective way to improve compliance and
help direct further interventions to ensure adherence in women on anti-estrogen therapy for
breast cancer.
Inclusion Criteria:
- 18 years of age or older
- Estrogen receptor positive (> 1% estrogen expression) by immunohistochemistry
- Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine
therapy
Exclusion Criteria:
- Patients with metastatic disease (stage IV)
- Patients less than 18 years of age
- Prisoners
- Patients are unable to fill prescriptions at the BCC pharmacy due to insurance
limitations or personal preference
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Elizabeth C Riley, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
James Graham Brown Cancer Center- U of Louisville
Authority:
United States: Institutional Review Board
Study ID:
BCC-BRE-12-Adherence
NCT ID:
NCT01694225
Start Date:
July 2012
Completion Date:
July 2015
Related Keywords:
- Breast Cancer
- Breast cancer
- Anti-estrogen therapy
- Breast Neoplasms
Name | Location |
|---|---|
| James Graham Brown Cancer Center-University of Louisville | Louisville, Kentucky 40202 |
